Cargando…

Vitamin D supplementation and serum neurofilament light chain in interferon‐beta‐1b‐treated MS patients

OBJECTIVES: Serum neurofilament light chain (sNfL) is a promising biomarker of MS activity, progression, and treatment response. The aim of the present study was to address whether sNfL concentrations are affected by supplementation of vitamin D and correlate with disease activity in interferon‐beta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hänninen, Katariina, Jääskeläinen, Olli, Herukka, Sanna‐Kaisa, Soilu‐Hänninen, Merja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507359/ https://www.ncbi.nlm.nih.gov/pubmed/32705821 http://dx.doi.org/10.1002/brb3.1772

Ejemplares similares

Serum neurofilament light chain in FTLD: association with C9orf72, clinical phenotype, and prognosis
por: Cajanus, Antti, et al.
Publicado: (2020)

Plasma Neurofilament Light Chain (NF-L) Is a Prognostic Biomarker for Cortical Damage Evolution but Not for Cognitive Impairment or Epileptogenesis Following Experimental TBI
por: Heiskanen, Mette, et al.
Publicado: (2022)

A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment
por: Åivo, J., et al.
Publicado: (2012)

Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders
por: Katisko, Kasper, et al.
Publicado: (2019)

Thalamic Atrophy Without Whole Brain Atrophy Is Associated With Absence of 2-Year NEDA in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2019)

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis
por: Hänninen, Katariina, et al.
Publicado: (2020)

Exposure to systemic antibiotics in outpatient care and the risk of multiple sclerosis
por: Sipilä, Jussi OT, et al.
Publicado: (2023)

Initial treatment strategy and clinical outcomes in Finnish MS patients: a propensity-matched study
por: Hänninen, K., et al.
Publicado: (2021)

Circulating neurofilament is linked with morbid obesity, renal function, and brain density
por: Rebelos, Eleni, et al.
Publicado: (2022)

Comorbid epilepsy in Finnish patients with adult-onset Huntington’s disease
por: Sipilä, Jussi O. T., et al.
Publicado: (2016)

Low Cerebrospinal Fluid Amyloid-Beta Concentration Is Associated with Poorer Delayed Memory Recall in Women
por: Haapalinna, Fanni, et al.
Publicado: (2016)

Parechovirus infection preceding Guillain–Barré syndrome
por: Linden, Saara, et al.
Publicado: (2012)

Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study
por: Sipilä, Jussi O. T., et al.
Publicado: (2019)

Is CSF neurofilament light chain measurement relevant for MS?
por: Matsui, Makoto
Publicado: (2020)

Neurofilament light chain levels in MS: At the doorstep of clinical application
por: Dalmau, Josep
Publicado: (2019)

Epidemiology of Guillain‐Barré syndrome in Finland 2004–2014
por: Sipilä, Jussi O.T., et al.
Publicado: (2017)

Neurofilament light level correlates with brain atrophy, and cognitive and motor performance
por: Kartau, Marge, et al.
Publicado: (2023)

Rare PMP22 variants in mild to severe neuropathy uncorrelated to plasma GDF15 or neurofilament light
por: Palu, Edouard, et al.
Publicado: (2023)

Medication adherence/persistence among patients with active multiple sclerosis in Finland
por: Lahdenperä, Sanni, et al.
Publicado: (2020)

Neurofilament light chain predicts disease activity in relapsing-remitting MS
por: Varhaug, Kristin N., et al.
Publicado: (2017)

Serum neurofilament light chains in MS: Association with the Timed Up and Go
por: Allali, Gilles, et al.
Publicado: (2020)

Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation
por: Thebault, Simon, et al.
Publicado: (2021)

Neurofilament light chain level is a weak risk factor for the development of MS
por: Arrambide, Georgina, et al.
Publicado: (2016)

CSF neurofilament light chain testing as an aid to determine treatment strategies in MS
por: Reyes, Saúl, et al.
Publicado: (2020)

Serum neurofilament light chain in relapsing-remitting MS: Unchaining disease activity prediction?
por: Marrie, Ruth Ann
Publicado: (2017)

CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration
por: Pawlitzki, Marc, et al.
Publicado: (2018)

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
por: Kuhle, Jens, et al.
Publicado: (2019)

Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MS
por: Aktas, Orhan, et al.
Publicado: (2020)

Chitinase 3–like 1 and neurofilament light chain in CSF and CNS atrophy in MS
por: Schneider, Ruth, et al.
Publicado: (2020)

Neurofilament light chain: defining the analyte
por: Leckey, Claire A., et al.
Publicado: (2022)

Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons
por: Sainio, Markus T., et al.
Publicado: (2022)

High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS
por: Thebault, Simon, et al.
Publicado: (2019)

Serum neurofilament light chain and optical coherence tomography measures in MS: A longitudinal study
por: Tavazzi, Eleonora, et al.
Publicado: (2020)

The CERAD Neuropsychological Battery in Patients with Frontotemporal Lobar Degeneration
por: Haanpää, Ramona M., et al.
Publicado: (2015)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Neurofilament light chain in the vitreous humor of the eye
por: Subramanian, Manju L., et al.
Publicado: (2020)

Blood Neurofilament Light Chain: The Neurologist’s Troponin?
por: Thebault, Simon, et al.
Publicado: (2020)

The Evolution of Neurofilament Light Chain in Multiple Sclerosis
por: Ferreira-Atuesta, Carolina, et al.
Publicado: (2021)

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis
por: Pukoli, Dániel, et al.
Publicado: (2021)

Neurofilament light chain concentration in an aging population
por: Ladang, Aurélie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2gh0lrbi1244sjlt6ncuq5moag